Regeneron Pharmaceuticals Inc. (REGN) Social Stream
REGENERON PHARMACEUTICALS INC (REGN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering REGN.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 16 | $850 | $565 | $683.266 | $913.17 | -25.18% |
| 2021-11-10 | 16 | $850 | $565 | $687.266 | $913.17 | -24.74% |
| 2021-11-19 | 16 | $850 | $565 | $697.266 | $913.17 | -23.64% |
| 2021-12-07 | 16 | $850 | $570 | $701.266 | $913.17 | -23.21% |
| 2021-12-09 | 18 | $850 | $570 | $704.312 | $913.17 | -22.87% |
| 2021-12-28 | 18 | $850 | $570 | $705.812 | $913.17 | -22.71% |
| 2022-01-03 | 18 | $850 | $570 | $705.812 | $913.17 | -22.71% |
| 2022-01-04 | 18 | $850 | $570 | $705.812 | $913.17 | -22.71% |
| 2022-01-05 | 18 | $850 | $570 | $699.562 | $913.17 | -23.39% |
| 2022-01-10 | 15 | $844 | $575 | $706.846 | $913.17 | -22.59% |
| 2022-01-21 | 15 | $844 | $575 | $704.384 | $913.17 | -22.86% |
| 2022-01-28 | 14 | $844 | $575 | $704.384 | $913.17 | -22.86% |
| 2022-02-07 | 14 | $843 | $575 | $704.153 | $913.17 | -22.89% |
| 2022-03-21 | 13 | $843 | $575 | $696.416 | $913.17 | -23.74% |
| 2022-04-04 | 13 | $843 | $565 | $695.583 | $913.17 | -23.83% |
| 2022-04-12 | 12 | $780 | $565 | $688.272 | $913.17 | -24.63% |
| 2022-05-04 | 11 | $780 | $565 | $688.727 | $913.17 | -24.58% |
| 2022-05-05 | 12 | $780 | $565 | $689.727 | $913.17 | -24.47% |
| 2022-05-18 | 13 | $780 | $565 | $686.454 | $913.17 | -24.83% |
| 2022-05-23 | 14 | $780 | $575 | $691.583 | $913.17 | -24.27% |
| 2022-06-03 | 15 | $780 | $550 | $687.416 | $913.17 | -24.72% |
| 2022-06-06 | 15 | $780 | $536 | $676.923 | $913.17 | -25.87% |
| 2022-08-02 | 16 | $780 | $536 | $665.785 | $913.17 | -27.09% |
| 2022-08-03 | 16 | $780 | $536 | $670 | $913.17 | -26.63% |
| 2022-08-04 | 17 | $788 | $536 | $667.5 | $913.17 | -26.9% |
| 2022-09-05 | 16 | $788 | $536 | $667.5 | $913.17 | -26.9% |
| 2022-09-14 | 18 | $925 | $550 | $750.066 | $913.17 | -17.86% |
| 2022-09-17 | 18 | $925 | $550 | $750.062 | $913.17 | -17.86% |
| 2022-09-26 | 18 | $925 | $550 | $757.187 | $913.17 | -17.08% |
| 2022-10-14 | 19 | $970 | $575 | $771.176 | $913.17 | -15.55% |
| 2022-10-17 | 19 | $970 | $575 | $770.555 | $913.17 | -15.62% |
| 2022-10-21 | 20 | $970 | $575 | $770.555 | $913.17 | -15.62% |
| 2022-11-03 | 21 | $970 | $575 | $779.789 | $913.17 | -14.61% |
| 2022-11-04 | 20 | $970 | $575 | $785.105 | $913.17 | -14.02% |
| 2022-11-11 | 21 | $970 | $550 | $786.736 | $913.17 | -13.85% |
| 2022-12-01 | 21 | $970 | $575 | $788.052 | $913.17 | -13.7% |
| 2022-12-15 | 21 | $970 | $595 | $789.105 | $913.17 | -13.59% |
| 2022-12-16 | 21 | $970 | $595 | $794.368 | $913.17 | -13.01% |
| 2023-01-04 | 21 | $970 | $595 | $801.833 | $913.17 | -12.19% |
| 2023-01-11 | 20 | $970 | $595 | $801.833 | $913.17 | -12.19% |
| 2023-01-23 | 20 | $970 | $595 | $801.833 | $913.17 | -12.19% |
| 2023-01-26 | 20 | $970 | $595 | $802.111 | $913.17 | -12.16% |
| 2023-01-27 | 20 | $970 | $605 | $802.666 | $913.17 | -12.1% |
| 2023-02-06 | 22 | $970 | $605 | $814.277 | $913.17 | -10.83% |
| 2023-02-13 | 22 | $970 | $605 | $812.5 | $913.17 | -11.02% |
| 2023-02-24 | 22 | $970 | $605 | $812.6 | $913.17 | -11.01% |
| 2023-03-09 | 22 | $970 | $605 | $813.55 | $913.17 | -10.91% |
| 2023-03-20 | 22 | $970 | $605 | $813.35 | $913.17 | -10.93% |
| 2023-03-23 | 22 | $970 | $605 | $816.3 | $913.17 | -10.61% |
| 2023-03-24 | 22 | $970 | $605 | $828.8 | $913.17 | -9.24% |
| 2023-03-28 | 22 | $1040 | $605 | $861.45 | $913.17 | -5.66% |
| 2023-03-30 | 22 | $1040 | $650 | $864.45 | $913.17 | -5.34% |
| 2023-03-31 | 22 | $1040 | $650 | $866.95 | $913.17 | -5.06% |
| 2023-04-05 | 22 | $1040 | $650 | $867.35 | $913.17 | -5.02% |
| 2023-04-12 | 22 | $1040 | $650 | $867.2 | $913.17 | -5.03% |
| 2023-04-18 | 22 | $1040 | $650 | $871.7 | $913.17 | -4.54% |
| 2023-05-03 | 22 | $1040 | $650 | $872.2 | $913.17 | -4.49% |
| 2023-05-05 | 22 | $1050 | $650 | $881.9 | $913.17 | -3.42% |
| 2023-05-31 | 22 | $1050 | $650 | $881.4 | $913.17 | -3.48% |
| 2023-06-06 | 21 | $1050 | $650 | $881.4 | $913.17 | -3.48% |
| 2023-06-27 | 21 | $1050 | $650 | $881.65 | $913.17 | -3.45% |
| 2023-06-28 | 21 | $1045 | $650 | $869.3 | $913.17 | -4.8% |
| 2023-07-03 | 21 | $1045 | $650 | $867.35 | $913.17 | -5.02% |
| 2023-07-06 | 21 | $1045 | $650 | $866.35 | $913.17 | -5.13% |
| 2023-07-11 | 21 | $1045 | $650 | $863.157 | $913.17 | -5.48% |
| 2023-07-19 | 21 | $1045 | $650 | $863.1 | $913.17 | -5.48% |
| 2023-08-03 | 21 | $1045 | $650 | $859.1 | $913.17 | -5.92% |
| 2023-08-04 | 21 | $1045 | $650 | $866.5 | $913.17 | -5.11% |
| 2023-08-07 | 21 | $1045 | $650 | $868.9 | $913.17 | -4.85% |
| 2023-08-21 | 21 | $1050 | $605 | $887.25 | $913.17 | -2.84% |
| 2023-09-28 | 23 | $1050 | $665 | $898.5 | $913.17 | -1.61% |
| 2023-10-02 | 23 | $1050 | $680 | $899.25 | $913.17 | -1.52% |
| 2023-10-13 | 23 | $1050 | $680 | $895.684 | $913.17 | -1.91% |
| 2023-10-18 | 23 | $1050 | $680 | $906.944 | $913.17 | -0.68% |
| 2023-11-01 | 22 | $1050 | $680 | $906.944 | $913.17 | -0.68% |
| 2023-11-03 | 22 | $1050 | $680 | $906.944 | $913.17 | -0.68% |
| 2023-11-04 | 22 | $1066 | $680 | $916.631 | $913.17 | 0.38% |
| 2023-11-28 | 23 | $1066 | $680 | $910.8 | $913.17 | -0.26% |
| 2023-12-06 | 23 | $1066 | $680 | $910.9 | $913.17 | -0.25% |
| 2023-12-11 | 23 | $1066 | $680 | $915.9 | $913.17 | 0.3% |
| 2023-12-12 | 22 | $1066 | $680 | $914.105 | $913.17 | 0.1% |
| 2023-12-13 | 21 | $1066 | $680 | $917 | $913.17 | 0.42% |
| 2023-12-22 | 21 | $1066 | $700 | $919.611 | $913.17 | 0.71% |
| 2023-12-27 | 21 | $1125 | $700 | $923.777 | $913.17 | 1.16% |
| 2023-12-29 | 21 | $1125 | $700 | $928.666 | $913.17 | 1.7% |
The Trend in the Analyst Price Target
Over the past 14 months, REGN's average price target has gone up $140.61.
REGN reports an average of 11.21% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-16 | 21 | 1050 | 650 | 881.650 | 783.05 | 12.59% |
| 2023-07-06 | 21 | 1045 | 650 | 866.350 | 704.83 | 22.92% |
| 2023-08-04 | 21 | 1045 | 650 | 866.500 | 766.44 | 13.06% |
| 2023-12-15 | 21 | 1066 | 700 | 919.611 | 859.14 | 7.04% |
| 2023-12-20 | 21 | 1066 | 700 | 919.611 | 841.79 | 9.24% |
REGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.62 | 15 | 0 | 5 | 0 | 0 | 21 |
The Trend in the Broker Recommendations
REGN's average broker recommendation rating improved by 0 over the prior 39 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, REGENERON PHARMACEUTICALS INC's average analyst price target is greater than 10330.86% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, REGENERON PHARMACEUTICALS INC's number of analysts covering the stock is higher than 9726.3% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, REGENERON PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 886.18% of them.
- In terms of how REGENERON PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -2746.56% of that group.
Stocks similar to REGENERON PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BMY, DNLI, and ARGX.
View All Top Stocks by Price Target
What is the outlook for REGN? Use POWR Ratings for clearer insight into price direction.